Morgan Stanley's Base Case on Shopify (SHOP) Suggests 71% Upside, Bull Case 207%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Wedbush Starts Shopify (SHOP) at Outperform
January 21, 2016 7:28 AM ESTWedbush initiates coverage on Shopify (NYSE: SHOP) with a Outperform rating and a price target of $25.00.
Analyst Gil Luria commented, "We believe ecommerce enablers are best positioned to take advantage of the secular shift of retail online and that Shopify represents a best-in-class... More
Pre-Open Stock Movers 01/19: (RSE) (ZPIN) (SHOP) Higher; (EBIO) (TIF) (MKC) Lower (more...)
January 19, 2016 9:33 AM ESTEleven Biotherapeutics, Inc. (NASDAQ: EBIO) 64% LOWER; announced top-line results from the Phase 3 clinical trial of its lead drug candidate, isunakinra (EBI-005), for the treatment of severe allergic conjunctivitis. In this trial, there were no statistically significant differences between the isunakinra treated group and the vehicle control group on the primary endpoint of ocular itching or on any secondary endpoints. Isunakinra was generally well tolerated, with 94% of the patients completing the trial and there were no serious adverse events reported.
Rouse Properties, Inc. (NYSE:... More
Morgan Stanley Upgrades Shopify (SHOP) to Overweight
January 19, 2016 6:47 AM ESTMorgan Stanley upgraded Shopify (NYSE: SHOP) from Equalweight to Overweight.
For an analyst ratings summary and ratings history on Shopify click here. For more ratings news on Shopify click here.
Shares of Shopify closed at $19.89 yesterday.
... More